Ania Kelegama

Ms. Ania Kelegama


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 August 2025 in Biomolecules
Verified
Journal Article
Open access
PDF file
MLMary Law
Mary Law
ZDZaafir M. Dulloo
Zaafir M. Dulloo
BHBrian Hardy
Brian Hardy
AKAnia Kelegama
Ania Kelegama
RCReagan Clark
Reagan Clark
BLBrian K. Law
Brian K. Law
Protein Disulfide Isomerases (PDIs) are emerging targets in anticancer therapy, with several PDI inhibitors demonstrating anticancer efficacy in preclinical models. Research has largely focused on “canonical” PDIs, such as PDIA1, which contain CXXC active site motifs where C represents Cysteine. Canonical PDIs have well-studied, critical roles in forming, breaking, and exchanging/scrambling disulfide bonds during protein folding. In contrast, non-canonical PDIs, which harbor CXXS active site motifs, remain less well-studied despite their role as sensors or effectors of protein folding quality control during protein trafficking in the secretory pathway. Here, we provide a review of the literature relating to the non-canonical PDIs ERp44, AGR2, and AGR3, which have been identified as strong dependencies in specific cancer subtypes according to the DepMap database. The biological and biochemical functions of ERp44, AGR2, and AGR3 are discussed, highlighting the role of ERp44 in two mechanisms of protein folding quality control, AGR2 as a selective sensor of mucin protein misfolding, and a unique role for AGR3 in cilia. Finally, we discuss recent efforts to develop small molecule inhibitors of ERp44, AGR2, and AGR3 as tool compounds and experimental therapeutics.

15 May 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
MLMary Law
Mary Law
ZDZaafir Dulloo
Zaafir Dulloo
BHBrian Hardy
Brian Hardy
AKAnia Kelegama
Ania Kelegama
RCReagan Clark
Reagan Clark
BLBrian K. Law
Brian K. Law
Protein Disulfide Isomerases (PDIs) are emerging targets in anticancer therapy, with several PDI inhibitors demonstrating anticancer efficacy in preclinical models. Research has largely focused on “canonical” PDIs, such as PDIA1, which contain CXXC active site motifs where C represents Cysteine. Canonical PDIs have well-studied, critical roles in forming, breaking, and exchanging/scrambling disulfide bonds during protein folding. In contrast, non-canonical PDIs, which harbor CXXS active site motifs, remain less well-studied despite their role as sensors or effectors of protein folding quality control during protein trafficking in the secretory pathway. Here, we provide a review of the literature relating to the non-canonical PDIs ERp44, AGR2, and AGR3, which have been identified as strong dependencies in specific cancer subtypes according to the DepMap database. The biological and biochemical functions of ERp44, AGR2, and AGR3 are discussed, highlighting the role of ERp44 in two mechanisms of protein folding quality control, AGR2 as a selective sensor of mucin protein misfolding, and a unique role for AGR3 in cilia. Finally, we discuss recent efforts to develop small molecule inhibitors of ERp44, AGR2, and AGR3 as tool compounds and experimental therapeutics.

3 July 2024 in JMIR Preprints
Verified
Preprint
Open access
JCJohn Francisco Cabrera
John Francisco Cabrera
MMMakenna Lorryn Myrick
Makenna Lorryn Myrick
CKClaudia Klejc
Claudia Klejc
AKAnia Kelegama
Ania Kelegama
BACKGROUND Kidney Transplantations (KTs) are a complicated surgical procedure with significant technical skill required. Traditional training methods for surgical residents, such as cadaver and porcine models, have limitations including high costs, low reusability, and ethical concerns. 3D surgical training models have increasingly been used to supplement the surgical training of medical students. This study introduces a protocol to test such a training model for kidney transplantations, focusing on the capacity of the model to enhance surgical skills, confidence, and understanding among surgical residents. OBJECTIVE The aim of this study is to assess the impact of using 3D surgical training models on medical residents' competency in kidney transplantation through self-reported ratings, memory-based questions, and performance analysis. Our population of interest is first year surgical residents currently in residency rotations within the University of Florida (UF) Division of Transplantation and Hepatobiliary Surgery, which is a division of UF Health Shands Emergency Hospital. For the purposes of our study, we will exclude surgical residents at UF Health Shands Hospital with previous kidney transplantation training. METHODS First year surgical residents at the University of Florida will be randomly assigned to either an experimental group using 3D model trainers or a control group with no training. Both groups will complete pre and post-training assessments, including Likert Scale-based confidence surveys, procedural step ordering, and anatomical structure labeling. Paired sample t-tests (P = .05) and Root Mean Square tests will be used for data analysis. RESULTS As of July 2024, our 3D model has been completed, and we have received an IRB exempt study status. CONCLUSIONS This study presents a protocol for testing a 3D box model trainer for kidney transplants. Results from this protocol could support the incorporation of 3D box model trainers into surgical training programs, highlighting their potential to improve technical skills, confidence, and understanding of laparoscopic cholecystectomies among surgical residents.